UnitedHealth Group has become the poster child for how AI reshapes insurance, according to Auxier Asset Management’s latest investor letter. The health benefits company is among the firms that have successfully integrated AI into their operations, and Auxier points to its administrative functions as proof of the technology’s power.
The firm’s Q2 2026 letter highlights UnitedHealth’s work as a material contributor to its portfolio. The company has automated transcription of patient encounters, which has helped reduce clinician burnout. Management reports generating about $2 of value for every $1 spent on AI due to reductions in manual labor. That figure comes from current CEO Stephen Hemsley, whose measured approach to AI implementation has been a key strategy during his tenure.
On September 14, 2026, UnitedHealth Group closed at $383.55 per share. Over the past month, the stock declined 4.38%. Its 52-week performance is stronger: shares gained 10.86% over the past 52 weeks. The company carries a market capitalization of $344.27 billion, with a 52-week trading range between $255.97 and $461.62.
The letter describes several specific ways AI has changed how UnitedHealth operates. Administrative functions have been transformed through increased automation and efficiency. Automated transcription of patient encounters has reduced clinician burnout, a persistent problem in healthcare.
Management’s $2-to-$1 return figure is notable. For every dollar spent on AI, the company generates two dollars in value. The source attributes this measured approach directly to CEO Stephen Hemsley.
Other insurers are following a similar path. Cigna Group is projecting $200 million in medical cost savings over the next three years thanks to its AI-enabled predictive models. Elevance, Humana and CVS have also been using AI-enabled tools to help lower medical costs.
These examples support Auxier’s argument that AI can benefit companies without the high upfront cost of building the infrastructure themselves. The technology’s potential on the user side is being demonstrated across the industry.
Auxier Asset Management continues to focus on identifying enduring businesses with strong competitive advantages, resilient cash flows, and sustainable long-term growth potential. The firm’s concerns include rising margin debt, increased leverage, and elevated capital flows into high-growth technology areas, which could amplify future volatility.
The letter also directs readers to the fund’s top five holdings to see its best picks in 2026. Those holdings are not detailed in the excerpt provided.
The fund’s own performance supports that thesis. The Auxier Focus Fund’s Investor Class gained 8.82% in the second quarter, and 10.70% for the six months ended June 30, 2026. The S&P 500 gained 15.2% in the quarter, driven by accelerating capital spending toward AI infrastructure.
UnitedHealth Group’s AI work is clearly resonating with investors. The stock’s 52-week gain of 10.86% reflects investor appetite for companies putting AI to work, even as the broader market has been driven by AI infrastructure spending.
The question Auxier’s letter leaves open is whether the AI-driven gains are sustainable. The firm’s concerns about margin debt, leverage, and volatile capital flows suggest caution, even as it holds onto UnitedHealth.
| Metric | Value |
|---|---|
| UnitedHealth close on Sept 14, 2026 | $383.55 |
| Monthly decline | 4.38% |
| 52-week gain | 10.86% |
| Market cap | $344.27 billion |
| 52-week trading range | $255.97 to $461.62 |
| S&P 500 Q2 gain | 15.2% |
| Fund Q2 gain | 8.82% |
| Fund six-month gain | 10.70% |
For investors tracking the intersection of healthcare and technology, UnitedHealth Group remains a bellwether. Its measured approach to AI implementation, as described by Auxier, shows how companies can capture value without betting everything on new infrastructure.
Whether that model scales across the industry remains to be seen. For now, the evidence points to a company that has found a way to put AI to work without breaking the bank.
Get the Notebook.
The day's best stories and every fresh verdict, in plain English, in your inbox by seven. One email a day, no more.